17
Days Left
Lead Plaintiff Deadline
Sep 21, 2026
Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your brokerage account with SnapTrade.
The filed complaint alleges that Microvast Holdings, Inc made materially false and/or misleading statements and/or failed to disclose that: (i) due to inventory management issues and delays in commercial vehicle rollouts by Microvast’s customers, defendants had overstated Microvast’s ability to reach its margin targets; (ii) defendants overstated Microvast’s ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.
In order to be eligible to join the MVST class action lawsuit, you must have incurred a loss on shares of Microvast Holdings, Inc. purchased during the class period listed above.
If you suffered a loss in Microvast Holdings, Inc. during the relevant time frame or pursuant to the relevant offering(s), you have until September 21, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
● The Allegation: The complaint alleges Microvast overstated its ability to meet gross margin targets and complete its Huzhou Phase 3.2 expansion by the end of 2025. Plaintiffs claim defendants failed to disclose inventory management issues and delays in customer commercial vehicle rollouts.
● The Stock Drop: MVST fell $0.79 per share, or 34.2%, to close at $1.52 per share on March 17, 2026, after Microvast reported sharply lower gross margin, a revenue miss, inventory impairment charges, and customer platform ramp-up delays; MVST fell as much as $0.40, or approximately 10.23%, before closing at $3.90 per share on June 25, 2025, after the Grizzly Research report; MVST fell $0.30, or approximately 9.93%, to close at $2.72 per share on August 4, 2025, after the company announced Chief Financial Officer Carl T. Schultz's departure; MVST fell $0.50, or approximately 10%, to close at $4.48 per share on November 11, 2025, after Microvast disclosed that Huzhou Phase 3.2 production would begin in Q1 2026.
● Class Period & Defendants: The class period runs from April 1, 2025 through March 16, 2026, inclusive. Defendants are Microvast Holdings, Inc., Yang Wu (Founder, Chief Executive Officer, and Chairman of the Board), Fariyal Khanbabi (Chief Financial Officer from the start of the Class Period until April 7, 2025), Carl T. Schultz (Chief Financial Officer from April 21, 2025 to July 29, 2025), and Rodney Worthen (Interim Chief Financial Officer from August 7, 2025 until January 7, 2026, and Chief Financial Officer from January 7, 2026 through the remainder of the Class Period).
● Lead Plaintiff Deadline: September 21, 2026. Investors who wish to seek appointment as lead plaintiff must apply by the deadline. No action is required before the deadline to remain a potential class member.
|
Microvast Class Action Summary |
|
|
Company |
Microvast Holdings, Inc. (NASDAQ: MVST) |
|
Lead Plaintiff Deadline |
September 21, 2026 |
|
Class Period |
April 1, 2025 - March 16, 2026 |
|
Stock Drop |
March 17, 2026 - MVST fell $0.79 (34.2%) to $1.52; June 25, 2025 - MVST fell as much as $0.40 (approximately 10.23%) to $3.90; August 4, 2025 - MVST fell $0.30 (approximately 9.93%) to $2.72; November 11, 2025 - MVST fell $0.50 (approximately 10%) to $4.48 |
A securities class action lawsuit has been filed against Microvast Holdings, Inc. and certain top executives. The lawsuit was filed on behalf of investors who purchased or otherwise acquired Microvast securities from April 1, 2025 through March 16, 2026.
The complaint alleges defendants made materially false and misleading statements about margins and the Huzhou Phase 3.2 expansion. Microvast said it could reach margin targets and bring new capacity online in 2025.
Plaintiffs claim the company later revealed margin pressure, inventory impairment charges, and customer rollout delays. MVST fell 34.2% on March 17, 2026, after the final alleged disclosure.
Microvast Holdings, Inc. designs, develops, and manufactures battery components and systems primarily for electric commercial vehicles and energy storage systems. The company is headquartered in Stafford, Texas, and its common stock trades on the Nasdaq Capital Market under the ticker MVST.
April 1, 2025-March 16, 2026
Investors who purchased or acquired Microvast Holdings, Inc. (MVST) securities during the Class Period may be eligible to seek recovery under the federal securities laws.
The Microvast securities lawsuit alleges that defendants repeatedly told investors the company's business was positioned for growth, margin improvement, and increased production capacity. At the start of the Class Period, Microvast touted record quarterly revenue, a backlog of $401.3 million, and its Huzhou Phase 3.2 expansion, which it said would add up to 2 gigawatt hours per year of production capacity.
On March 31, 2025, Microvast issued its FY 2024 earnings release. On April 1, 2025, the company held an earnings call in which Yang Wu said Microvast anticipated first qualified production from Huzhou Phase 3.2 in the fourth quarter of 2025. Fariyal Khanbabi also highlighted gross margin improvement, which she attributed to operational efficiencies, increased utilization, disciplined cost control, and a strategic repositioning away from low-margin segments.
The complaint further alleges that Microvast repeated these themes in May and August 2025. In its May 12, 2025 quarterly release and Q1 earnings call, the company reiterated a full-year gross margin target of approximately 30% and said Huzhou Phase 3.2 was on track for first qualified production in Q4 2025. On August 11, 2025, Microvast raised its gross margin target from 30% to 32% and again said the Huzhou expansion was expected to come online later that year.
According to plaintiffs, those statements were materially false and misleading because defendants failed to disclose that inventory management issues and delays in commercial vehicle rollouts by Microvast's customers threatened the company's margin targets. The complaint also alleges defendants overstated Microvast's ability to complete the Huzhou Phase 3.2 expansion by the end of 2025, while periodic filings failed to disclose the scope and severity of those risks under Item 105 of Regulation S-K.
The first alleged corrective disclosure came on June 25, 2025, when short seller Grizzly Research issued a report claiming that Microvast "is fabricating a significant part of its business and capabilities." The report alleged that Microvast overstated activity at its production facilities, including Huzhou, and overstated the prospective economic value of commercial partnerships.
A second development followed on August 1, 2025, when Microvast announced that Carl T. Schultz had ceased serving as Chief Financial Officer just over three months after joining the company. The complaint alleges the terse announcement gave no explanation for his departure, which came amid what plaintiffs describe as significant turnover in Microvast's Chief Financial Officer role.
The alleged truth continued to emerge on November 10, 2025, when Microvast disclosed that it expected to finish installation and commissioning for Huzhou Phase 3.2 by year-end, with initial production to follow. During the related conference call, Wu stated for the first time that initial production was expected to begin in Q1 2026. On March 16, 2026, Microvast then reported quarterly revenue of $96.5 million, a 15% year-over-year decrease and below the $136.4 million consensus estimate, along with gross margin of approximately 1% and a $32.5 million inventory impairment charge related to specialized ESS components.
Following the Grizzly Research report on June 25, 2025, MVST fell as much as $0.40 per share, or approximately 10.23%, before closing at $3.90 per share. After the August 1, 2025 Chief Financial Officer departure announcement, the stock fell $0.30 per share, or approximately 9.93%, to close at $2.72 per share on August 4, 2025.
According to the complaint, the November 2025 Huzhou Phase 3.2 disclosure was followed by another decline, with MVST falling $0.50 per share, or approximately 10%, to close at $4.48 per share on November 11, 2025. The largest alleged stock drop came after Microvast's March 16, 2026 results, when MVST fell $0.79 per share, or 34.2%, to close at $1.52 per share on March 17, 2026.
● Lead Plaintiff Deadline: September 21, 2026
● After the lead plaintiff deadline, the Court will consider any lead plaintiff motions.
● Defendants may file a motion to dismiss.
● If the case proceeds, the Court may later consider class certification.
Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. Prior results do not guarantee similar outcomes.
The Microvast Holdings, Inc. shareholder lawsuit alleges that the company and certain executives made materially false and misleading statements during the Class Period. According to the complaint, defendants overstated Microvast's ability to meet gross margin targets and complete the Huzhou Phase 3.2 expansion by the end of 2025. Plaintiffs allege the company failed to disclose inventory management issues and delays in customer commercial vehicle rollouts that threatened those targets.
The complaint defines the Class as all persons and entities, other than defendants and excluded parties, who purchased or otherwise acquired Microvast securities between April 1, 2025 and March 16, 2026, inclusive, and were damaged upon the revelation of the alleged corrective disclosures. Investors who acquired MVST securities during that period may fall within the proposed class definition, subject to the court's later rulings.
The complaint alleges Microvast repeatedly told investors that its Huzhou Phase 3.2 expansion would add up to 2 gigawatt hours of annual production capacity and come online in 2025. On April 1 and May 12, 2025, Yang Wu said the company anticipated first qualified production in the fourth quarter of 2025. Plaintiffs allege those statements overstated the company's ability to complete the expansion by year-end.
According to plaintiffs, Microvast told investors it was targeting a gross margin of approximately 30% for 2025, later raising that target to 32% and then to a range of 32% to 35%. The complaint alleges those statements lacked a reasonable basis because inventory management issues and delays in commercial vehicle rollouts by Microvast customers threatened the company's ability to meet those margin targets.
The complaint identifies several alleged corrective disclosures. On June 25, 2025, Grizzly Research published a report challenging Microvast's business and production claims. On August 1, 2025, the company announced the departure of Chief Financial Officer Carl T. Schultz. On November 10, 2025, Microvast disclosed that Huzhou Phase 3.2 production would begin in Q1 2026. On March 16, 2026, the company reported a revenue miss, approximately 1% quarterly gross margin, and inventory impairment charges.
MVST declined after each alleged disclosure identified in the complaint. The stock fell as much as $0.40 per share on June 25, 2025, then fell $0.30 per share to $2.72 on August 4, 2025. It later fell $0.50 per share to $4.48 on November 11, 2025. After the March 16, 2026 results, MVST fell $0.79 per share, or 34.2%, to close at $1.52 on March 17, 2026.
The defendants are Microvast Holdings, Inc. and four individual defendants. The complaint names Yang Wu, the company's Founder, Chief Executive Officer, and Chairman of the Board; Fariyal Khanbabi, Chief Financial Officer from the start of the Class Period until April 7, 2025; Carl T. Schultz, Chief Financial Officer from April 21, 2025 to July 29, 2025; and Rodney Worthen, Interim Chief Financial Officer and later Chief Financial Officer.
The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. Plaintiffs allege defendants made materially false and misleading statements, failed to disclose material adverse facts, and knew or recklessly disregarded that their statements misrepresented the true condition of Microvast's business, operations, and financial prospects.
The Microvast securities lawsuit alleges the company overstated its margin outlook and the timing of its Huzhou Phase 3.2 expansion. Plaintiffs claim defendants failed to disclose inventory issues and customer rollout delays that affected those targets.
The Class Period runs from April 1, 2025 through March 16, 2026, inclusive. Investors who purchased or acquired Microvast securities during that period may be included in the proposed class.
According to the complaint, MVST fell after Microvast reported quarterly revenue of $96.5 million, approximately 1% quarterly gross margin, and inventory impairment charges tied to specialized ESS components. The stock declined $0.79 per share, or 34.2%, to close at $1.52.
The complaint was filed by plaintiff Leah Graham on behalf of investors who purchased or otherwise acquired Microvast securities during the Class Period. The case was filed in the United States District Court for the Southern District of Texas, Houston Division.
The lead plaintiff deadline is September 21, 2026. This deadline applies only to investors seeking appointment as lead plaintiff.
Deadline
Sep 21, 2026